Literature DB >> 20173319

Current-day prevalence of Ménière's syndrome.

Jeffrey P Harris1, Thomas H Alexander.   

Abstract

Previously reported prevalence rates of Ménière's syndrome (MS) have ranged from 3.5 per 100000 to 513 per 100000. Recent data regarding the prevalence in the United States are lacking. To further assess the current-day prevalence of MS in the US, data from a medical and pharmaceutical claims database containing information for over 60 million unique patients were analyzed. Patients in the database are representative of the national, commercially insured population on a variety of demographic measures including age, gender, health plan type, and geographic location. A 3-year period from 2005 to 2007 was analyzed. The prevalence of MS was 190 per 100000 with a female:male ratio of 1.89:1. The prevalence increased with increasing age, ranging from 9 per 100000 for patients under age 18 to 440 per 100000 for patients 65 years and older. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20173319     DOI: 10.1159/000286213

Source DB:  PubMed          Journal:  Audiol Neurootol        ISSN: 1420-3030            Impact factor:   1.854


  25 in total

1.  Chronic cerebrospinal venous insufficiency in patients with Ménière's disease.

Authors:  R Filipo; F Ciciarello; G Attanasio; P Mancini; E Covelli; L Agati; F Fedele; M Viccaro
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-12-07       Impact factor: 2.503

Review 2.  Vestibular dysfunction: prevalence, impact and need for targeted treatment.

Authors:  Yuri Agrawal; Bryan K Ward; Lloyd B Minor
Journal:  J Vestib Res       Date:  2013       Impact factor: 2.435

Review 3. 

Authors:  Vincent Wu; Edward A Sykes; Michael M Beyea; Matthew T W Simpson; Jason A Beyea
Journal:  Can Fam Physician       Date:  2019-07       Impact factor: 3.275

4.  Therapeutic strategies in the treatment of Menière's disease: the Italian experience.

Authors:  Nicola Quaranta; P Picciotti; G Porro; B Sterlicchio; G Danesi; P Petrone; Giacinto Asprella Libonati
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-04-11       Impact factor: 2.503

5.  Balanced sex distribution in patients with Menière's disease.

Authors:  Sandra Becker-Bense; Constanze Wittmann; Marianne Dieterich
Journal:  J Neurol       Date:  2019-04-10       Impact factor: 4.849

6.  Association of Obstructive Sleep Apnea With the Risk of Ménière's Disease and Sudden Sensorineural Hearing Loss: A Study Using Data From the Korean National Health Insurance Service.

Authors:  Jong-Yeup Kim; Inseok Ko; Bum-Joo Cho; Dong-Kyu Kim
Journal:  J Clin Sleep Med       Date:  2019-09-15       Impact factor: 4.062

7.  RNA-sequencing study of peripheral blood mononuclear cells in sporadic Ménière's disease patients: possible contribution of immunologic dysfunction to the development of this disorder.

Authors:  Y Sun; D Zhang; G Sun; Y Lv; Y Li; X Li; Y Song; J Li; Z Fan; H Wang
Journal:  Clin Exp Immunol       Date:  2017-12-11       Impact factor: 4.330

8.  Sequential bilateral cochlear implantation in a patient with bilateral Ménière's disease.

Authors:  Laura K Holden; J Gail Neely; Brenda D Gotter; Karen M Mispagel; Jill B Firszt
Journal:  J Am Acad Audiol       Date:  2012-04       Impact factor: 1.664

Review 9.  Approach to Ménière disease management.

Authors:  Vincent Wu; Edward A Sykes; Michael M Beyea; Matthew T W Simpson; Jason A Beyea
Journal:  Can Fam Physician       Date:  2019-07       Impact factor: 3.275

10.  Clinical and Audio Vestibular Profile of Meniere's Disease in a Tertiary Care Centre in India.

Authors:  Paul Selvakumar; Achamma Balraj; Regi Kurien; Thenmozhi Krishnan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.